Cytori Therapeutics, Inc. Release: Enrollment Completed for Investigator-Initiated Stem & Regenerative Cell Breast Augmentation Study in Japan

TOKYO--(BUSINESS WIRE)--Enrollment was completed in a 20 patient investigator-initiated study in Japan using adipose-derived stem and regenerative cells in breast augmentation procedures. The study, which began November 2007, is evaluating a procedure whereby a woman’s fat tissue is enriched with her own adipose derived stem and regenerative cells to create a natural filler. This technique is referred to as ‘cell-enhanced reconstruction.’

MORE ON THIS TOPIC